曲美他嗪联合三磷腺苷治疗冠心病合并心功能不全的临床疗效.docVIP

精品论文 参考文献 曲美他嗪联合三磷腺苷治疗冠心病合并心功能不全的临床疗效 姚雪婷 　　武汉市第三医院 中医科 湖北武汉 430060 　　【摘 要】目的：曲美他嗪联合三磷腺苷治疗冠心病合并心功能不全的临床疗效。 方法：计算机随机检索选取60例2013年1月—2014年1月期间在我院冠心病合并心功能不全患者，随机分为对照组（30例）和试验组（30例）。对照组患者被给予曲美他嗪治疗，试验组患者被给予曲美他嗪＋三磷腺苷联合治疗，分析两种疗法的临床疗效。结果：试验组的治疗有效率（100.00%）优于对照组患者（80.00%），试验组的自觉症状评分（88.63plusmn;5.12）优于对照组（52.13plusmn;3.21），试验组的心血管事件发生次数（1.60plusmn;0.54）优于对照组（6.21plusmn;3.12），试验组的LVEF/％（68.87plusmn;6.12）优于对照组（40.12plusmn;4.21），试验组的患者满意度（100.00%）优于对照组（80.00%），两组患者的数据差异具有统计学意义（Plt;0.05）。结论：曲美他嗪联合三磷腺苷治疗冠心病合并心功能不全的临床疗效显著，改善患者心功能，值得临床推广应用。 　　【关键词】曲美他嗪；三磷腺苷；冠心病合并心功能不全；临床疗效 　　【中图分类号】R972 【文献标识码】B 【文章编号】1674-8999（2015）8-0209-02 　　Clinical efficacy of trimetazidine combined with adenosine triphosphate (ATP)in the treatment of CHD and cardiac insufficiency 　　【Abstract】Objective:To analyze the clinical efficacy of trimetazidine combined with adenosine triphosphate (ATP)in the treatment of CHD and cardiac insufficiency.Methods:60 patients with CHD and cardiac insufficiency in our hospital from Mar 2013 to Mar 2014 were selected as the study objects,and divided them into control group and experimental group,30 cases in each group.The control group was treated by trimetazidine ,the experimental group was treated by trimetazidine combined with ATP,clinical efficacy of two groups were comparatively analyzed.Results:The significant efficiency of experimental group （100.00%）was better than control group (80.00%),the subjective symptom score of experimental group (88.63plusmn;5.12) was better than control group (52.13plusmn;3.21),and the attack times of cardiovascular event in experimental group (1.60plusmn;0.54) was better than control group (6.21plusmn;3.12),the LVEF/％ of experimental group （68.87plusmn;6.12）was better than control group（40.12plusmn;4.21）,the satisfaction degree of experimental group was 100.00%,it was better than control group (80.00%),differences between two groups were statistically significant.Conclusion:The clincial efficacy of trimetazidine combined with in th